Caspofungin Acetate or Fluconazole in Preventing Invasive Fungal Infections in Patients With Acute Myeloid Leukemia Who Are Undergoing Chemotherapy
Conditions
Fungal Infection | Leukemia | Neutropenia
What is the purpose of this trial?
RATIONALE: Caspofungin acetate or fluconazole may help prevent fungal infections caused by chemotherapy. It is not yet known whether fluconazole is more effective than caspofungin acetate in preventing fungal infections in patients with acute myeloid leukemia who are undergoing chemotherapy.
PURPOSE: This randomized phase III clinical trial is studying caspofungin acetate to see how it works compared to fluconazole in preventing invasive fungal infections in patients with acute myeloid leukemia who are undergoing chemotherapy.
Participation Guidelines
- Age:
- Up to 30 Years
- Gender:
- Both
Click here for detailed information about who can participate in this trial.
- Sponsor:
- Children's Oncology Group
National Cancer Institute (NCI) - Dates:
- April 2011
- Last Updated:
- February 19, 2012
- Study HIC#:
- 1112009412
Clinicaltrials.gov ID: NCT01307579
For more information about this trial, contact:
Investigator
Nina Kadan-Lottick, MD
Principal Investigator
